Works matching AU Yamasaki, Masahiro


Results: 93
    1
    2
    3
    4
    5
    6
    7

    Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism.

    Published in:
    Medical Molecular Morphology, 2021, v. 54, n. 1, p. 60, doi. 10.1007/s00795-020-00259-1
    By:
    • Honma, Yuichi;
    • Karasuyama, Tsukasa;
    • Kumamoto, Keiichiro;
    • Shimajiri, Shohei;
    • Toki, Yasumichi;
    • Tatsumi, Yasuaki;
    • Sumida, Kazuhiro;
    • Koikawa, Kenji;
    • Morino, Kahori;
    • Oe, Shinji;
    • Miyagawa, Koichiro;
    • Yamasaki, Masahiro;
    • Shibata, Michihiko;
    • Abe, Shintaro;
    • Ikuta, Katsuya;
    • Hayashi, Hisao;
    • Harada, Masaru
    Publication type:
    Article
    8

    Fgf10 is essential for limb and lung formation.

    Published in:
    Nature Genetics, 1999, v. 21, n. 1, p. 138, doi. 10.1038/5096
    By:
    • Sekine, Keisuke;
    • Ohuchi, Hideyo;
    • Fujiwara, Masanori;
    • Yamasaki, Masahiro;
    • Yoshizawa, Tatsuya;
    • Sato, Takashi;
    • Yagishita, Naoko;
    • Matsui, Daisuke;
    • Koga, Yoshihiko;
    • Itoh, Nobuyuki;
    • Kato, Shigeaki
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 2, p. 1, doi. 10.1007/s00432-024-05618-4
    By:
    • Kuribayashi, Tadahiro;
    • Ohashi, Kadoaki;
    • Nishii, Kazuya;
    • Ninomiya, Kiichiro;
    • Tsubata, Yukari;
    • Ishikawa, Nobuhisa;
    • Kodani, Masahiro;
    • Kanaji, Nobuhiro;
    • Yamasaki, Masahiro;
    • Fujitaka, Kazunori;
    • Kuyama, Shoichi;
    • Takigawa, Nagio;
    • Fujimoto, Nobukazu;
    • Kubota, Tetsuya;
    • Inoue, Masaaki;
    • Fujiwara, Keiichi;
    • Harita, Shingo;
    • Takata, Ichiro;
    • Takada, Kenji;
    • Okawa, Sachi
    Publication type:
    Article
    15

    First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 8, p. 1869, doi. 10.1007/s00432-021-03893-z
    By:
    • Kudo, Kenichiro;
    • Nishii, Kazuya;
    • Makimoto, Go;
    • Ishikawa, Nobuhisa;
    • Tsubata, Yukari;
    • Kodani, Masahiro;
    • Fujimoto, Nobukazu;
    • Yamasaki, Masahiro;
    • Kubota, Tetsuya;
    • Takigawa, Nagio;
    • Fujitaka, Kazunori;
    • Kanaji, Nobuhiro;
    • Shibayama, Takuo;
    • Itano, Junko;
    • Ando, Chihiro;
    • Hotta, Katsuyuki;
    • Kiura, Katsuyuki
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Anti-babesial compounds from Curcuma xanthorrhiza.

    Published in:
    Natural Product Research, 2007, v. 21, n. 4, p. 328, doi. 10.1080/14786410701192934
    By:
    • Matsuura, Hideyuki;
    • Nomura, Shinkichi;
    • Subeki;
    • Yamada, Kazuaki;
    • Yamasaki, Masahiro;
    • Yamato, Osamu;
    • Maede, Yoshimitsu;
    • Katakura, Ken;
    • Trimurningsih;
    • Chairul;
    • Yoshihara, Teruhiko;
    • Nabeta, Kensuke
    Publication type:
    Article
    28
    29
    30
    31
    32

    ENDOSCOPIC PROCEDURE UNDER IRRIGATION.

    Published in:
    Digestive Endoscopy, 2005, v. 17, n. 3, p. 241, doi. 10.1111/j.1443-1661.2005.00531.x
    By:
    • Kume, Keiichiro;
    • Yamasaki, Masahiro;
    • Kanda, Kikuo;
    • Yoshikawa, Ichiro;
    • Otsuki, Makoto
    Publication type:
    Article
    33

    Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221110171
    By:
    • Tsubata, Yukari;
    • Hotta, Takamasa;
    • Hamai, Kosuke;
    • Furuya, Naoki;
    • Yokoyama, Toshihide;
    • Saito, Ryota;
    • Nakamura, Atsushi;
    • Masuda, Takeshi;
    • Hamaguchi, Megumi;
    • Kuyama, Shoichi;
    • Honda, Ryoichi;
    • Senoo, Tadashi;
    • Nakanishi, Masamoto;
    • Yamasaki, Masahiro;
    • Ishikawa, Nobuhisa;
    • Fujitaka, Kazunori;
    • Kubota, Tetsuya;
    • Ohtsu, Hiroshi;
    • Kobayashi, Kunihiko;
    • Isobe, Takeshi
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer.

    Published in:
    Cancers, 2022, v. 14, n. 24, p. 6236, doi. 10.3390/cancers14246236
    By:
    • Daido, Wakako;
    • Masuda, Takeshi;
    • Imano, Nobuki;
    • Matsumoto, Naoko;
    • Hamai, Kosuke;
    • Iwamoto, Yasuo;
    • Takayama, Yusuke;
    • Ueno, Sayaka;
    • Sumii, Masahiko;
    • Shoda, Hiroyasu;
    • Ishikawa, Nobuhisa;
    • Yamasaki, Masahiro;
    • Nishimura, Yoshifumi;
    • Kawase, Shigeo;
    • Shiota, Naoki;
    • Awaya, Yoshikazu;
    • Suzuki, Tomoko;
    • Kitaguchi, Soichi;
    • Fujitaka, Kazunori;
    • Nagata, Yasushi
    Publication type:
    Article
    42

    Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study.

    Published in:
    Cancers, 2022, v. 14, n. 2, p. 331, doi. 10.3390/cancers14020331
    By:
    • Mimori, Tomoyasu;
    • Shukuya, Takehito;
    • Ko, Ryo;
    • Okuma, Yusuke;
    • Koizumi, Tomonobu;
    • Imai, Hisao;
    • Takiguchi, Yuichi;
    • Miyauchi, Eisaku;
    • Kagamu, Hiroshi;
    • Sugiyama, Tomohide;
    • Azuma, Keisuke;
    • Namba, Yukiko;
    • Yamasaki, Masahiro;
    • Tanaka, Hisashi;
    • Takashima, Yuta;
    • Soda, Sayo;
    • Ishimoto, Osamu;
    • Koyama, Nobuyuki;
    • Kobayashi, Kunihiko;
    • Takahashi, Kazuhisa
    Publication type:
    Article
    43
    44
    45
    46

    Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 69, doi. 10.1007/s10147-022-02257-y
    By:
    • Tsubata, Yukari;
    • Kawakado, Keita;
    • Hamai, Kosuke;
    • Furuya, Naoki;
    • Yokoyama, Toshihide;
    • Saito, Ryota;
    • Nakamura, Atsushi;
    • Masuda, Takeshi;
    • Hamaguchi, Megumi;
    • Kuyama, Shoichi;
    • Honda, Ryoichi;
    • Senoo, Tadashi;
    • Nakanishi, Masamoto;
    • Hotta, Takamasa;
    • Yamasaki, Masahiro;
    • Ishikawa, Nobuhisa;
    • Fujitaka, Kazunori;
    • Kubota, Tetsuya;
    • Kobayashi, Kunihiko;
    • Isobe, Takeshi
    Publication type:
    Article
    47
    48

    Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.

    Published in:
    Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
    By:
    • Ko, Ryo;
    • Shukuya, Takehito;
    • Okuma, Yusuke;
    • Tateishi, Kazunari;
    • Imai, Hisao;
    • Iwasawa, Shunichiro;
    • Miyauchi, Eisaku;
    • Fujiwara, Akiko;
    • Sugiyama, Tomohide;
    • Azuma, Keisuke;
    • Muraki, Keiko;
    • Yamasaki, Masahiro;
    • Tanaka, Hisashi;
    • Takashima, Yuta;
    • Soda, Sayo;
    • Ishimoto, Osamu;
    • Koyama, Nobuyuki;
    • Morita, Satoshi;
    • Kobayashi, Kunihiko;
    • Nukiwa, Toshihiro
    Publication type:
    Article
    49
    50